Evidence map›Paper›PMID 8913744›Full record

ArticleGenetics1996

Asm-1+, a Neurospora crassa gene related to transcriptional regulators of fungal development.

R Aramayo, Y Peleg, R Addison, R Metzenberg

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 117 citations in OpenAlex.

  1. Properties of Putative APSES Transcription Factor AfpA inJournal of fungi (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Meiotic Silencing in DothideomycetousFrontiers in fungal biology · 2022
    Article
  7. Transcription FactorJournal of fungi (Basel, Switzerland) · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R AramayoDepartment of Biomolecular Chemistry, University of Wisconsin, Madison 53706, USA.
Y Peleg
R Addison
R Metzenberg
University of Wisconsin–Madison · US

Funding

NIGMS NIH HHS GM-08945
6 · The paper itself

Abstract

This report describes the identification, cloning, and molecular analysis of Asm-1+ (Ascospore maturation 1), the Neurospora crassa homologue of the Aspergillus nidulans stuA (stunted A) gene. The Asm-1+ gene is constitutively transcribed and encodes an abundant, nucleus-localized 68.5-kD protein. The protein product of Asm-1+ (ASM-1), contains a potential DNA-binding motif present in related proteins from A. nidulans (StuA), Candida albicans (EFGTF-1), and Saccharomyces cerevisiae (Phd1 and Sok2). This motif is related to the DNA binding motif of the Swi4/Mbp1/Res family of transcription factors that control the cell cycle. Deletion of Asm-1+ destroys the ability to make protoperithecia (female organs), but does not affect male-specific functions. We propose that the APSES domain (ASM-1, Phd1, StuA, EFGTF-1, and Sok2) defines a group of proteins that constitute a family of related transcription factors involved in the control of fungal development.

Indexed as

Fungal ProteinsGene Expression Regulation, FungalGenes, RegulatorTranscription, GeneticAmino Acid SequenceBase SequenceCell NucleusCloning, MolecularDNA, FungalGene DeletionMolecular Sequence DataNeurospora crassaSequence Homology, Amino AcidTranscription FactorsASM-1 protein, Neurospora crassaDNA, FungalFungal ProteinsTranscription Factors

Identifiers

PMID8913744
PMCPMC1207638
OpenAlexW1876617638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.